Farzadfar F, Naghavi M, Sepanlou SG, Moghaddam SS, Dangel WJ, Weaver ND, et al. Health system performance in Iran: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2022;399(10335):1625–45.
Moazzeni SS, Ghafelehbashi H, Hasheminia M, Parizadeh D, Ghanbarian A, Azizi F, et al. Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011. BMC Public Health. 2020;20:1–9.
Bayati M, Kiadaliri A. Contributions of avoidable mortality to the sex gap in life expectancy and life disparity in Iran. Archives Public Health. 2023;81(1):126.
Farzadfar F, Yousefi M, Jafari-Khounigh A, Khorrami Z, Haghdoost A, Shadmani FK. Trend and projection of non-communicable diseases risk factors in Iran from 2001 to 2030. Sci Rep. 2024;14(1):8092.
Article CAS PubMed PubMed Central Google Scholar
Ramezankhani A, Azizi F, Momenan AA, Hadaegh F. Sex differences in cumulative exposure to metabolic risk factors before hypertension onset: the cohort of the tehran lipid and glucose study. J Am Heart Association. 2021;10(23):e021922.
Jackson SS, Marks MA, Katki HA, Cook MB, Hyun N, Freedman ND, et al. Sex disparities in the incidence of 21 cancer types: quantification of the contribution of risk factors. Cancer. 2022;128(19):3531–40.
Rashidi M-M, Saeedi Moghaddam S, Azadnajafabad S, Mohammadi E, Khalaji A, Malekpour M-R, et al. Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the global burden of Disease Study 2019. Clin Kidney J. 2024;17(1):sfad279.
Tabatabaei-Malazy O, Saeedi Moghaddam S, Khashayar P, Keykhaei M, Tehrani YS, Malekpour M-R, et al. Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; results from global burden of disease study 2019. Front Public Health. 2022;10:1015902.
Article PubMed PubMed Central Google Scholar
Ramezankhani A, Azizi F, Hadaegh F. Sex differences in risk factors for coronary heart disease events: a prospective cohort study in Iran. Sci Rep. 2023;13(1):22398.
Article CAS PubMed PubMed Central Google Scholar
Ahmadi B, Alimohammadian M, Yaseri M, Majidi A, Boreiri M, Islami F, et al. Multimorbidity: epidemiology and risk factors in the Golestan cohort study, Iran: a cross-sectional analysis. Medicine. 2016;95(7):e2756.
Article PubMed PubMed Central Google Scholar
Colafella KMM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018;14(3):185–201.
Ngaruiya C. When women win, we all win—call for a gendered global NCD agenda. FASEB BioAdvances. 2022;4(12):741.
Article PubMed PubMed Central Google Scholar
Baune B, Bhandari D, Ciobanu L, Lalloo R, Lassi Z, Noubiap Nzeale J. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. 2020.
Abbasi-Kangevari M, Saeedi Moghaddam S, Ghamari S-H, Azangou-Khyavy M, Malekpour M-R, Rezaei N, et al. The burden of prostate cancer in North Africa and Middle East, 1990–2019: findings from the global burden of disease study. Front Oncol. 2022;12:961086.
Article PubMed PubMed Central Google Scholar
Khadembashiri MM, Ghasemi E, Khadembashiri MA, Azadnajafabad S, Moghaddam SS, Eslami M, et al. The global, regional, and national burden and quality of care index of kidney cancer; a global burden of disease systematic analysis 1990–2019. Int J Qual Health Care. 2024;36(1):mzad113.
Collaborators G, Ärnlöv J. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1160–203.
Collaborators G, Ärnlöv J. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.
Emadi M, Delavari S, Bayati M. Global socioeconomic inequality in the burden of communicable and non-communicable diseases and injuries: an analysis on global burden of disease study 2019. BMC Public Health. 2021;21:1–13.
Pasdar Y, Najafi F, Moradinazar M, Shakiba E, Karim H, Hamzeh B, et al. Cohort profile: Ravansar Non-communicable Disease cohort study: the first cohort study in a kurdish population. Int J Epidemiol. 2019;48(3):682–f3.
Ahmadi A, Shirani M, Khaledifar A, Hashemzadeh M, Solati K, Kheiri S, et al. Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study. BMC Public Health. 2021;21:1–14.
Khosravi Shadmani F, Farzadfar F, Larijani B, Mirzaei M, Haghdoost AA. Trend and projection of mortality rate due to non-communicable diseases in Iran: a modeling study. PLoS ONE. 2019;14(2):e0211622.
Article CAS PubMed PubMed Central Google Scholar
Rezaei N, Ahmadi N, Shams Beyranvand M, Hasan M, Gohari K, Yoosefi M, et al. Alcohol consumption and related disorders in Iran: results from the national surveillance of non-communicable diseases’ survey (STEPs) 2016. PLOS Global Public Health. 2022;2(11):e0000107.
Article PubMed PubMed Central Google Scholar
Hakimi H, Ahmadi J, Vakilian A, Jamalizadeh A, Kamyab Z, Mehran M, et al. The profile of Rafsanjan cohort study. Eur J Epidemiol. 2021;36:243–52.
Article CAS PubMed Google Scholar
Dong M, Cioffi G, Wang J, Waite KA, Ostrom QT, Kruchko C, et al. Sex differences in cancer incidence and survival: a pan-cancer analysis. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1389–97.
Najari BB, Rink M, Li PS, Karakiewicz PI, Scherr DS, Shabsigh R, et al. Sex disparities in cancer mortality: the risks of being a man in the United States. J Urol. 2013;189(4):1470–4.
Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1174–82.
Article PubMed PubMed Central Google Scholar
Karimi A, Shobeiri P, Azadnajafabad S, Masinaei M, Rezaei N, Ghanbari A, et al. A global, regional, and national survey on burden and quality of Care Index (QCI) of bladder cancer: the global burden of disease study 1990–2019. PLoS ONE. 2022;17(10):e0275574.
Article CAS PubMed PubMed Central Google Scholar
McCartney G, Mahmood L, Leyland AH, Batty GD, Hunt K. Contribution of smoking-related and alcohol-related deaths to the gender gap in mortality: evidence from 30 European countries. Tob Control. 2011;20(2):166–8.
Clocchiatti A, Cora E, Zhang Y, Dotto GP. Sexual dimorphism in cancer. Nat Rev Cancer. 2016;16(5):330–9.
Article CAS PubMed Google Scholar
Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008;8(9):737–44.
Article CAS PubMed PubMed Central Google Scholar
Hyde Z, Flicker L, McCaul KA, Almeida OP, Hankey GJ, Chubb SP, et al. Associations between testosterone levels and incident prostate, lung, and colorectal cancer. A population-based study. Cancer Epidemiol Biomarkers Prev. 2012;21(8):1319–29.
Article CAS PubMed Google Scholar
Watts EL, Perez-Cornago A, Knuppel A, Tsilidis KK, Key TJ, Travis RC. Prospective analyses of testosterone and sex hormone‐binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK Biobank. Int J Cancer. 2021;149(3):573–84.
Article CAS PubMed Google Scholar
Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–38.
留言 (0)